BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24819480)

  • 1. COMT gene and risk for Parkinson's disease: a systematic review and meta-analysis.
    Jiménez-Jiménez FJ; Alonso-Navarro H; García-Martín E; Agúndez JA
    Pharmacogenet Genomics; 2014 Jul; 24(7):331-9. PubMed ID: 24819480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson's Disease: A Meta-Analysis and Systematic Review.
    Dwivedi A; Dwivedi N; Kumar A; Singh VK; Pathak A; Chaurasia RN; Mishra VN; Mohanty S; Joshi D
    J Geriatr Psychiatry Neurol; 2023 Mar; 36(2):98-106. PubMed ID: 35603896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COMT Val158Met polymorphism as an associated risk factor for Parkinson's disease in Asian rather than Caucasian populations.
    Lechun L; Yu S; Pengling H; Changqi H
    Neurol India; 2013; 61(1):12-6. PubMed ID: 23466833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
    Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
    Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
    Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
    BMC Neurol; 2011 Jul; 11():89. PubMed ID: 21781348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.
    Michałowska M; Chalimoniuk M; Jówko E; Przybylska I; Langfort J; Toczylowska B; Krygowska-Wajs A; Fiszer U
    Brain Behav; 2020 Mar; 10(3):e01537. PubMed ID: 32022467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PITX3 and risk for Parkinson's disease: a systematic review and meta-analysis.
    Jiménez-Jiménez FJ; García-Martín E; Alonso-Navarro H; Agúndez JA
    Eur Neurol; 2014; 71(1-2):49-56. PubMed ID: 24525476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
    Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.
    Sampaio TF; Dos Santos EUD; de Lima GDC; Dos Anjos RSG; da Silva RC; Asano AGC; Asano NMJ; Crovella S; de Souza PRE
    J Clin Pharmacol; 2018 Jul; 58(7):920-926. PubMed ID: 29578580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variations in catechol-O-methyltransferase gene are associated with levodopa response variability in Chinese patients with Parkinson's disease.
    Zhao C; Wang Y; Zhang B; Yue Y; Zhang J
    Sci Rep; 2020 Jun; 10(1):9521. PubMed ID: 32533012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD.
    Zhang Y; Piao X; Wu J; Li Y; Liang Q
    Int J Neurosci; 2016; 126(5):400-7. PubMed ID: 26000819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson's disease-a meta-analysis.
    Yin Y; Liu Y; Xu M; Zhang X; Li C
    Neurol Sci; 2021 Oct; 42(10):4085-4094. PubMed ID: 34346015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update.
    Okochi T; Ikeda M; Kishi T; Kawashima K; Kinoshita Y; Kitajima T; Yamanouchi Y; Tomita M; Inada T; Ozaki N; Iwata N
    Schizophr Res; 2009 May; 110(1-3):140-8. PubMed ID: 19329282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis.
    Zhang Z; Lindpaintner K; Che R; He Z; Wang P; Yang P; Feng G; He L; Shi Y
    J Neural Transm (Vienna); 2009 Oct; 116(10):1193-200. PubMed ID: 19578924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.
    Klebe S; Golmard JL; Nalls MA; Saad M; Singleton AB; Bras JM; Hardy J; Simon-Sanchez J; Heutink P; Kuhlenbäumer G; Charfi R; Klein C; Hagenah J; Gasser T; Wurster I; Lesage S; Lorenz D; Deuschl G; Durif F; Pollak P; Damier P; Tison F; Durr A; Amouyel P; Lambert JC; Tzourio C; Maubaret C; Charbonnier-Beaupel F; Tahiri K; Vidailhet M; Martinez M; Brice A; Corvol JC; ;
    J Neurol Neurosurg Psychiatry; 2013 Jun; 84(6):666-73. PubMed ID: 23408064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson's disease.
    Lin CH; Chaudhuri KR; Fan JY; Ko CI; Rizos A; Chang CW; Lin HI; Wu YR
    Sci Rep; 2017 Jul; 7(1):6306. PubMed ID: 28740224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers.
    Zhang Y; Hua S; Zhang A; Kong X; Jiang C; Deng D; Wenlong B
    Clin Lung Cancer; 2013 Jan; 14(1):45-9. PubMed ID: 22658813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.
    Hao H; Shao M; An J; Chen C; Feng X; Xie S; Gu Z; Chan P;
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1041-5. PubMed ID: 25034874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.